Masterflex SE

Investor Presentation • Apr 2, 2024

Earnings Call Presentation 2024

28 March 2024

01 _ Overview

02 _ Key Figures 2023 03 _ Outlook 2024 04 _ Appendix

AGENDA

Page 02

Page

01

Group operating EBIT grew by 10.4% to EUR 12.6 million (2022: EUR 11.4 million)

05

Increase in Group equity to EUR 57.6 million (2022: EUR 52.0 million); solid 02 equity ratio of 61.5% (2022: 57.6%)

Stable and high demand dynamics in the aviation business, life science sector and medical technology

06

Liquidity expanded despite increase in working capital - cash and bank balances rise to EUR 11.0 million (2022: EUR 9.7 03 million)

Rising share of high-margin revenue – revenue share from medical technology increases from 17% in 2022 to 19% in 2023

07

04

Significant increase in profitability from 11.4% to 12.4% in the operating EBIT

Order backlog as of 31.12.2023 remains at a high level at EUR 20.5 million (2022: EUR 22.8 million)

Dividend increase of 25% to EUR 0.25 per share 08 (2022: EUR 0.20) planned

Page 04

Key Figures 2023

Page

06

§ Stable revenue despite stagnating or declining development in cyclically sensitive customer sectors

§ Double-digit EBIT margin consolidated - to 12.4% (2022: 11.4%)

§ Improved material usage ratio of 31.8% (2022: 34.2%) thanks to productivity improvements and increased use of recyclate

§ Rising personnel costs were offset by higher productivity

in EUR million	2023	2022	Change
Revenue	101.1	100.3	+0.8%
EBITDA	17.9	16.4	+8.7%
EBIT (operating)	12.6	11.4	+10.4%
Group result	8.0	7.8	+2.8%
EPS (in EUR)	0.83	0.81	+2.8%

Strong full year 2023

-

-

Individual quarters 2023

Operating EBIT by quarter in EUR million

Revenue by quarter in EUR million

§ EBIT increase thanks to higher productivity and further cost reductions

§ EBIT margin rises to 12.4%

Page 08

Rising Group equity in the fiscal year 2023

§ Consolidated equity increases to EUR 57.6 million as at 31.12.2023 due to the positive earnings situation (31.12.2022: EUR 52.0 million)

§ Increase in cash and cash equivalents as of 31.12.2023 to EUR 11.0 million (31.12.2022: EUR 9.7 million) driven by increase in operating result

§ Net debt reduced to EUR 13.1 million (31.12.2022: EUR 16.8 million)

§ Earnings per share increase to EUR 0.83 (2022: EUR 0.81)

§ Dividend of EUR 0.25 per share planned (+25%)

Equity increased further

Group equity and equity ratio in EUR million

30,0 34,0 38,0 42,0 46,0 50,0 54,0 58,0 62,0

Dividend/EPS

Masterflex share and analyst ratings

Page 09

Montega Research 13.03.2024 BUY – 15.00 EUR

SMC Research 13.03.2024 BUY – 14.30 EUR

Metzler 11.03.2024 BUY – 13.50

Page

Outlook 2024

Page

11

Stable and robust growth expected in medical technology, aerospace, life science and other specialist industries

Business development resistant to economic cycles due to focus on a large number of sectors

Order backlog of EUR 20.5 million as at 31.12.2023 remains at a sufficiently high level

Operating EBIT expected in the range of EUR 12 million to EUR 15 million in 2024 (2023: EUR 12.4 million)

Further structural improvements and

diversification of growth strategy Revenue growth for 2024 expected between EUR 100 million to EUR 107 million (2023: EUR 101.1 million)

Outlook Medium-term forecast

Page 12

"The Company phase ahead of us is marked by growth."

§ Increasing digitalisation and further internationalisation coupled with organic and

§ Additional leverage through organic growth and acquisitions to achieve revenue level of EUR 200 million by 2030 - focus shifts towards organic growth thanks to

• inorganic growth form the strategic basis for long-term growth
• robust growth perspective
• § Further increase in profitability thanks to the use of economies of scale

§ Extended product and service range in the circular economy planned based on Ampius hose system - more detailed communication on this in early summer

§ Focus on megatrends such as green energy, semiconductors, life science, medical technology and a suitable portfolio of solutions ensures sustainable growth

Masterflex at a glance

Revenue in EUR million

20 EBITDA in EUR million

0369

12

15

EBIT (operating ) in EUR million

0.35

Financial Calendar 2024

Page

15

23 April	Metzler Small Cap Days
8 May	Quarterly Statement 1/2024
12 June	Annual General Meeting 2024
7 August	Half-Year Report 2024
21 – 23 August	HIT - Hamburger Investors Day
6 November	Quarterly Statement 3/2024
13 November	Munich Capital Markets Conference

Contact Investor Relations

Page 16

Masterflex SE Mark Becks, CFO Willy-Brandt-Allee 300 45891 Gelsenkirchen

CROSS ALLIANCE communication GmbH Susan Hoffmeister Bahnhofstr. 98 82166 Graefelfing/Munich

Phone

Tel.: +49 209 97077 0 Fax: +49 209 97077 33 Tel.: +49 89 125 09 03 33

Online

ir@masterflexgroup.com sh@crossalliance.de